Case Study Shows Efficacy from Tocilizumab in Patient With COVID-19, Myeloma

A case study of a patient in Wuhan, China demonstrated that tocilizumab may be an effective treatment for very ill patients with COVID-19 who also have multiple myeloma and other blood cancers.

Source: CancerNetwork - April 9, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news